DEVELOPMENT OF AN OFF-THE-SHELF CAR T-CELL THERAPY FOR HIV: A STEP TOWARDS A UNIVERSALLY ACCESSIBLE ADVANCED THERAPY

被引：0
|
作者：
Mlambo, T. [2 ]
Roussel-Gervais, A. [1 ]
Ilmjarv, S. [1 ,3 ]
Sakic, A. [1 ]
Myburgh, R. [6 ]
Bredl, S. [2 ]
Salmon, P. [3 ]
Pepper, M. [5 ]
Krause, K. [3 ,4 ]
Speck, R. F. [2 ]
Alessandrini, M. [1 ,3 ]
机构：
[1] Antion Biosci, Geneva, Switzerland
[2] Univ Spital Zurich, Infect Dis, Zurich, Switzerland
[3] Univ Geneva, Pathol & Immunol, Geneva, Switzerland
[4] Hop Univ Geneve, Geneva, Switzerland
[5] Univ Pretoria, Immunol, Pretoria, Gauteng, South Africa
[6] Univ Spital Zurich, Haematol, Zurich, Switzerland
来源：
CYTOTHERAPY | 2021年 / 23卷 / 05期
关键词：
HIV infection; CAR T-cells; Gene silencing;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
506
引用
收藏
页码：S104 / S104
页数：1
相关论文
共 50 条
  • [1] Advances in Off-the-Shelf CAR T-Cell Therapy
    Benjamin, Reuben
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (03) : 155 - 157
  • [2] Off-the-shelf T-cell therapy
    Cooper, Laurence J. N.
    BLOOD, 2010, 116 (23) : 4741 - 4743
  • [3] "Off-the-Shelf" CAR T-Cell Therapy Tested in Pediatric B-Cell Leukemia
    Larkin, Howard
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (22): : 2201 - 2201
  • [4] An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies
    Xiang, Jingyu
    Devenport, Jessica M.
    Carter, Alun J.
    Staser, Karl W.
    Kim, Miriam Y.
    O'Neal, Julie
    Ritchey, Julie K.
    Rettig, Michael P.
    Gao, Feng
    Rettig, Garrett
    Turk, Rolf
    Lee, Byung Ha
    Cooper, Matthew L.
    DiPersio, John F.
    LEUKEMIA, 2023, 37 (12) : 2448 - 2456
  • [5] An “off-the-shelf” CD2 universal CAR-T therapy for T-cell malignancies
    Jingyu Xiang
    Jessica M. Devenport
    Alun J. Carter
    Karl W. Staser
    Miriam Y. Kim
    Julie O’ Neal
    Julie K. Ritchey
    Michael P. Rettig
    Feng Gao
    Garrett Rettig
    Rolf Turk
    Byung Ha Lee
    Matthew L. Cooper
    John F. DiPersio
    Leukemia, 2023, 37 : 2448 - 2456
  • [6] Allogeneic off-the-shelf CAR T-cell therapy for relapsed or refractory B-cell malignancies
    Shahid, Sanam
    Prockop, Susan E.
    Flynn, Georgia C.
    Mauguen, Audrey
    White, Charlie O.
    Bieler, Jennifer
    Mcavoy, Devin
    Hosszu, Kinga
    Cancio, Maria I.
    Jakubowski, Ann A.
    Scaradavou, Andromachi
    Boelens, Jaap Jan
    Sauter, Craig S.
    Perales, Miguel-Angel
    Giralt, Sergio A.
    Taylor, Clare
    Chaudhari, Jagrutiben
    Wang, Xiuyan
    Riviere, Isabelle
    Sadelain, Michel
    Brentjens, Renier J.
    Kernan, Nancy A.
    O'Reilly, Richard J.
    Curran, Kevin J.
    BLOOD ADVANCES, 2025, 9 (07) : 1644 - 1657
  • [7] “Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect
    Yuxin An
    Xin Jin
    Hongkai Zhang
    Meng Zhang
    Sadhana Mahara
    Wenyi Lu
    Mingfeng Zhao
    Current Treatment Options in Oncology, 2023, 24 : 409 - 441
  • [8] The paths and challenges of "off-the-shelf" CAR-T cell therapy: An overview of clinical trials
    Moradi, Vahid
    Omidkhoda, Azadeh
    Ahmadbeigi, Naser
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 169
  • [9] Development of Next-Generation, Off-the-Shelf CAR T-Cell Immunotherapies for Solid Tumors
    Pan, Yijia
    Jelcic, Mark
    Hosking, Martin
    Shirinbak, Soheila
    Shrestha, Bishwas
    Peralta, Eigen
    Witty, Alec
    Clarke, Raedun
    Robbins, Dave
    Lee, Tom T.
    MOLECULAR THERAPY, 2022, 30 (04) : 152 - 152
  • [10] Development of an Off-the-Shelf Chimeric Antigen Receptor (CAR)-T Cell Therapy for T-Cell Acute Lymphoblastic Leukemia (T-ALL) without Gene Editing
    Wong, Xing Fah Alex
    Ng, Josie
    Zheng, Simin
    Ismail, Rizal
    Qian, Hongliang
    Campana, Dario
    Tan, Ying Xim
    BLOOD, 2022, 140 : 2358 - 2359
12345